Amalgamated Financial’s West Pharmaceutical WST Stock Holding History

Amalgamated Financial’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$8.82M	Buy	+21,484	New	+$8.41M	0.07%	235

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Amalgamated Financial's WST Position: Q1 2022 in Review

Amalgamated Financial opened a new position in West Pharmaceutical (WST) in Q1 2022: 21,484 shares worth $8.82M. The stake represents 0.07% of the portfolio and ranks #235 among its holdings.

718 funds tracked by Wall St. Rank hold WST as of Q1 2022.

Amalgamated Financial held 21,484 shares of West Pharmaceutical worth $8.82M as of Q1 2022.
West Pharmaceutical was a new Amalgamated Financial position in Q1 2022.
West Pharmaceutical made up 0.07% of Amalgamated Financial's portfolio in Q1 2022, its #235 holding.
718 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.